A Non-Pharmacological Paradigm Captures the Complexity in the Mechanism of Action of Poliprotect Against Gastroesophageal Reflux Disease and Dyspepsia一种非药物治疗模式揭示了Poliprotect对抗胃食管反流病和消化不良的作用机制的复杂性INTERNATIONAL JOURNAL OF MOLECULAR SCIENCESIF4.92025-01-290OA
MOBILIZATION OF LYMPHATIC ENDOTHELIAL PRECURSORS CELLS AND LYMPHATIC NEOVASCULARIZATION IN PRIMARY SJOGREN'S SYNDROMEANNALS OF THE RHEUMATIC DISEASESIF20.62016-06-010PREAI
Circulating Interferon-Inducible Protein IFI16 Correlates With Clinical and Serological Features in Rheumatoid ArthritisARTHRITIS CARE & RESEARCHIF3.32016-03-2433OAAI
Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjogren's syndrome: a pilot studyCLINICAL AND EXPERIMENTAL IMMUNOLOGYIF3.82016-03-0335OAAI
Essential oil composition, polar compounds, glandular trichomes and biological activity of Hyssopus officinalis subsp aristatus (Godr.) Nyman from central ItalyINDUSTRIAL CROPS AND PRODUCTSIF6.22015-12-0171PREAI
The circulating interferon-inducible protein IFI16 correlates with clinical and serological features in Rheumatoid ArthritisCYTOKINEIF3.72015-11-010PREAI
INTERFERON GAMMA-INDUCIBLE PROTEIN 16 (IFI16) IN PRIMARY SJOGREN'S SYNDROME: A NOVEL PLAYER IN DISEASE PATHOGENESIS?ANNALS OF THE RHEUMATIC DISEASESIF20.62015-06-010PREAI
IL-17 PRODUCING PATHOGENIC T LYMPHOCYTES CO-EXPRESS CD20 AND ARE DEPLETED BY RITUXIMAB IN PRIMARY SJOGREN'S SYNDROME: A NOVEL TARGET FOR AN OLD WEAPONANNALS OF THE RHEUMATIC DISEASESIF20.62015-06-010PREAI
INTERFERON GAMMA-INDUCIBLE PROTEIN 16 (IFI16) IN RHEUMATOID ARTHRITIS: A NOVEL BIOMARKER FOR PULMONARY INVOLVEMENT?ANNALS OF THE RHEUMATIC DISEASESIF20.62015-06-011PREAI
Anticyclic Citrullinated Peptide Antibodies in Patients with Rheumatic Diseases other than Rheumatoid Arthritis: Clinical or Pathogenic Significance?JOURNAL OF RHEUMATOLOGYIF3.42015-06-013OAAI
T Regulatory and T Helper 17 Cells in Primary Sjogren's Syndrome: Facts and PerspectivesMEDIATORS OF INFLAMMATIONIF4.22015-04-2881OAAI
Altered Immunoregulation in Rheumatoid Arthritis: The Role of Regulatory T Cells and Proinflammatory Th17 Cells and Therapeutic ImplicationsMEDIATORS OF INFLAMMATIONIF4.22015-03-30110OAAI
A NOVEL THERAPEUTIC APPROACH IN SYSTEMIC RHEUMATIC AUTOIMMUNE DISORDERS: ENCAPSULATED HUMAN UMBILICAL CORD WHARTON JELLY-DERIVED MESENCHYMAL STEM CELLSANNALS OF THE RHEUMATIC DISEASESIF20.62015-03-010PREAI
TELOCYTES IN MINOR SALIVARY GLANDS OF PATIENTS WITH PRIMARY SJOGREN'S SYNDROME: ASSOCIATION WITH THE EXTENT OF INFLAMMATION AND ECTOPIC LYMPHONEOGENESISANNALS OF THE RHEUMATIC DISEASESIF20.62015-03-010PREAI
Unmasking the pathogenic role of IL-17 axis in primary Sjogren's syndrome: A new era for therapeutic targeting?AUTOIMMUNITY REVIEWSIF8.32014-12-0147PREAI
The role of T helper 17 cell subsets in Sjogren's syndrome: similarities and differences between mouse model and humansANNALS OF THE RHEUMATIC DISEASESIF20.62014-07-017PREAI
ROLE OF PLATELETS IN THE PATHOGENESIS OF OSTEOARTHRITIS AND BIOLOGICAL EFFECTS OF HYALURONIC ACID: IN VIVO AND IN VITRO STUDYANNALS OF THE RHEUMATIC DISEASESIF20.62014-06-012PREAI
CD4-CD8- T-cells in primary Sjogren's syndrome: Association with the extent of glandular involvementJOURNAL OF AUTOIMMUNITYIF72014-06-0166PREAI
ROLE OF PLATELETS IN THE PATHOGENESIS OF OSTEOARTHRITIS AND BIOLOGICAL EFFECTS OF HYALURONIC ACID: IN VIVO AND IN VITRO STUDYOSTEOARTHRITIS AND CARTILAGEIF92014-04-010OA
PATHOGENIC ROLE OF IL-17 PRODUCING DOUBLE NEGATIVE (DN) T CELLS IN PRIMARY SJOGREN'S SYNDROMEANNALS OF THE RHEUMATIC DISEASESIF20.62014-03-010PREAI